MENU

Quality. A Cannabis Lab's Business Plan and Operation Model

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Co-Founder, Phase 3 Lab Solutions
    Biography

      Developer and provider of ISO 17025 Management Systems to over 1,000 labs worldwide. 25 years of experience in the field of testing, ISO 17025, standards development, product safety and performance specifications, measurement, uncertainty, and calibration. Two years developing solutions specifically tailored for the Cannabis lab industry. John is a licensed professional engineer and an expert in laboratory operations and management. John holds a bachelor's degree in Mechanical Engineering from the University of Michigan and a master's degree in Management.


    Abstract

    Too often, cannabis labs are trying to open for business without the solid foundation of an ISO management system. This afterthought is detrimental to labs’ short and long term success as they struggle to produce reliable results and gain stability. Labs that begin with a quality mindset open doors for business quicker and generate sustainable revenue and profit. A quality business model depends on a logically structured management system that addresses how the laboratory operates and delivers accurate and reliable test results. With quality as a business plan and model, every decision is made within the context of delivering accurate and reliable test results. What is the scope of activities the laboratory wants to undertake? What instruments have those capabilities? What competency of staffing is required to operate those instruments? Which consumables? Within a structured management system, these questions, and more, will be answered leaving no doubt about the lab’s future success.

    Learning Objectives:

    1. Identify the common mistakes in planning and operating Cannabis Test Labs

    2. Identify the risks of poor-quality control to the public, producers and laboratory

    3. Explain how a business plan and model, based on an ISO 17025 management system, can help labs avoid the common mistakes and mitigate risks


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    APR 19, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more